- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine ; volume:8 ; number:1 ; day:20 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (20.12.2018), 1-10, 12.2018
- Creator
-
Bullard, Brianna L.
Corder, Brigette N.
Gorman, Matthew J.
Diamond, Michael S.
Weaver, Eric A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35755-z
- URN
-
urn:nbn:de:101:1-2019020100263670799398
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bullard, Brianna L.
- Corder, Brigette N.
- Gorman, Matthew J.
- Diamond, Michael S.
- Weaver, Eric A.
- SpringerLink (Online service)
Other Objects (12)
Development of a novel simian adenovirus 24 based vaccine vector
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Adenovirus vaccine vectors : influence of vector tropism and vector directed immunity on adaptive immune responses to transgenic antigens
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Novel Adenovirus Vector-Based Vaccines for HIV
Zika vector transmission risk in temperate Australia: a vector competence study
Vaccine Development for Zika Virus—Timelines and Strategies
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
Development of a novel simian adenovirus 24 based vaccine vector
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Adenovirus vaccine vectors : influence of vector tropism and vector directed immunity on adaptive immune responses to transgenic antigens
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Novel Adenovirus Vector-Based Vaccines for HIV
Zika vector transmission risk in temperate Australia: a vector competence study
Vaccine Development for Zika Virus—Timelines and Strategies
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
Development of a novel simian adenovirus 24 based vaccine vector
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Adenovirus vaccine vectors : influence of vector tropism and vector directed immunity on adaptive immune responses to transgenic antigens
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Novel Adenovirus Vector-Based Vaccines for HIV
Zika vector transmission risk in temperate Australia: a vector competence study
Vaccine Development for Zika Virus—Timelines and Strategies